论文部分内容阅读
目的比较研究CSII和MDII在初发的2型糖尿病患者中强化治疗的效果。方法新诊断的2型糖尿病住院患者随机分为两组,分别采用CSII和MDII治疗,监测两组患者治疗前后血糖、血糖达标时间、平均胰岛素用量、低血糖发生率、治疗后“缓解时间”等的变化。结果CSII与MDII组相比,在血糖达标所需的时间、胰岛素用量及低血糖发生率、治疗后“缓解时间”等方面均有差异,且差异有统计学意义。结论CSII和MDII对2型糖尿病患者强化治疗均有效,但CSII的综合治疗效果明显优于MDII。
Objective To compare the effects of CSII and MDII intensive treatment in newly diagnosed type 2 diabetic patients. Methods Inpatients with newly diagnosed type 2 diabetes mellitus were randomly divided into two groups and were treated with CSII and MDII respectively. Before and after treatment, blood glucose, time to blood glucose, average insulin dosage, incidence of hypoglycemia, post-treatment “remission time” The change. Results Compared with MDII group, CSII had differences in the time required for blood sugar to reach the target, the amount of insulin and the incidence of hypoglycemia, the “remission time” after treatment, and the difference was statistically significant. Conclusion Both CSII and MDII are effective in intensive treatment of type 2 diabetes mellitus, but the comprehensive therapeutic effect of CSII is better than that of MDII.